Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Chevron
CVX
|
+$331M |
| 2 |
Walmart
WMT
|
+$229M |
| 3 |
Linde
LIN
|
+$187M |
| 4 |
PayPal
PYPL
|
+$145M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$903M |
| 2 |
Uber
UBER
|
+$565M |
| 3 |
Exxon Mobil
XOM
|
+$450M |
| 4 |
Novo Nordisk
NVO
|
+$393M |
| 5 |
Apple
AAPL
|
+$317M |
Sector Composition
| 1 | Technology | 18.82% |
| 2 | Healthcare | 17.05% |
| 3 | Consumer Discretionary | 13.22% |
| 4 | Financials | 8.79% |
| 5 | Consumer Staples | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3176
WidePoint Corp
WYY
$55.3M
| $235K | ﹤0.01% |
90,600
+12,850
| +17% | +$33.3K |
|
3177
Zai Lab
ZLAB
$3.62B
| $235K | ﹤0.01% |
14,700
+3,800
| +35% | +$60.7K |
|
3178
Albany International
AIN
$1.78B
| $234K | ﹤0.01% |
2,500
-9,700
| -80% | -$908K |
|
3179
Harte-Hanks
HHS
$27.7M
| $234K | ﹤0.01% |
31,300
+1,200
| +4% | +$8.97K |
|
3180
Amkor Technology
AMKR
$6.25B
| $232K | ﹤0.01% |
+7,200
| New | +$232K |
|
3181
Globalstar
GSAT
$3.85B
| $230K | ﹤0.01% |
+10,429
| New | +$230K |
|
3182
CI&T Inc
CINT
$685M
| $229K | ﹤0.01% |
55,400
+8,500
| +18% | +$35.1K |
|
3183
HF Foods Group
HFFG
$182M
| $229K | ﹤0.01% |
65,300
+8,700
| +15% | +$30.5K |
|
3184
Lexeo Therapeutics
LXEO
$279M
| $229K | ﹤0.01% |
+14,576
| New | +$229K |
|
|
SASR
3185
DELISTED
Sandy Spring Bancorp Inc
SASR
| $228K | ﹤0.01% |
+9,837
| New | +$228K |
|
|
TEAD
3186
Teads Holding Co. Common Stock
TEAD
$159M
| $226K | ﹤0.01% |
57,300
-4,700
| -8% | -$18.5K |
|
3187
PotlatchDeltic
PCH
$3.3B
| $225K | ﹤0.01% |
4,776
-110,431
| -96% | -$5.2M |
|
3188
abrdn Physical Silver Shares ETF
SIVR
$2.56B
| $224K | ﹤0.01% |
9,400
-96,200
| -91% | -$2.29M |
|
|
AOMR
3189
Angel Oak Mortgage REIT
AOMR
$233M
| $223K | ﹤0.01% |
20,800
-12,100
| -37% | -$130K |
|
3190
Vanguard S&P Small-Cap 600 ETF
VIOO
$3.08B
| $223K | ﹤0.01% |
+2,200
| New | +$223K |
|
|
JBIO
3191
Jade Biosciences, Inc. Common Stock
JBIO
$251M
| $222K | ﹤0.01% |
+214
| New | +$222K |
|
3192
Pluri
PLUR
$40.5M
| $222K | ﹤0.01% |
34,387
+10,587
| +44% | +$68.3K |
|
3193
Sensei Biotherapeutics
SNSE
$11.7M
| $222K | ﹤0.01% |
10,550
+3,375
| +47% | +$71K |
|
3194
GEN Restaurant Group
GENK
$16.7M
| $221K | ﹤0.01% |
18,900
-2,600
| -12% | -$30.4K |
|
3195
The Oncology Institute
TOI
$295M
| $221K | ﹤0.01% |
140,100
+50,800
| +57% | +$80.1K |
|
3196
Imperial Petroleum
IMPP
$142M
| $220K | ﹤0.01% |
70,400
+7,600
| +12% | +$23.8K |
|
3197
Origin Materials
ORGN
$80.9M
| $220K | ﹤0.01% |
+430,500
| New | +$220K |
|
3198
Yunhong Green CTI Ltd
YHGJ
$17.6M
| $220K | ﹤0.01% |
138,182
+16
| +0% | +$25 |
|
3199
Rani Therapeutics
RANI
$24.1M
| $219K | ﹤0.01% |
70,300
+26,600
| +61% | +$82.9K |
|
3200
Tennant Co
TNC
$1.53B
| $219K | ﹤0.01% |
1,800
-55,200
| -97% | -$6.72M |
|